Labecor 100mg Tablet contains Labetalol, a non-selective beta-adrenergic receptor blocker with additional alpha-1 adrenergic receptor blocking activity, indicated primarily for the management of hypertension. By antagonizing both beta and alpha-1 receptors, Labetalol effectively reduces peripheral vascular resistance and heart rate, leading to a decrease in blood pressure without significant reflex tachycardia. This dual mechanism makes Labecor suitable for treating chronic hypertension, hypertensive emergencies, and conditions requiring rapid blood pressure control. The 100mg dosage provides a balanced therapeutic effect, often initiated under medical supervision and adjusted based on patient response and tolerability. Labecor is contraindicated in patients with bronchial asthma, overt cardiac failure, second- or third-degree atrioventricular block, and severe bradycardia. Common adverse effects may include dizziness, fatigue, nausea, and hypotension. Caution is advised in patients with diabetes mellitus, as Labetalol may mask hypoglycemic symptoms. Labecor should be administered with careful monitoring of blood pressure and heart rate, and abrupt discontinuation should be avoided to prevent rebound hypertension. This medication should be used under strict medical guidance, with dose adjustments tailored to individual patient needs to achieve optimal therapeutic outcomes.